1
|
A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
|
N Engl J Med
|
2006
|
5.74
|
2
|
Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
|
Lancet
|
2005
|
2.65
|
3
|
Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
|
J Clin Microbiol
|
2005
|
1.48
|
4
|
Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.
|
J Clin Microbiol
|
2007
|
1.29
|
5
|
Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.
|
J Clin Microbiol
|
2002
|
1.27
|
6
|
Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.
|
J Clin Microbiol
|
2003
|
1.27
|
7
|
Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia.
|
J Antimicrob Chemother
|
2002
|
1.23
|
8
|
Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum.
|
J Med Microbiol
|
2010
|
1.19
|
9
|
Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth.
|
FEMS Microbiol Lett
|
2009
|
1.02
|
10
|
Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung.
|
J Med Microbiol
|
2008
|
1.00
|
11
|
Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.
|
J Clin Microbiol
|
2009
|
0.95
|
12
|
Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis.
|
J Med Microbiol
|
2006
|
0.92
|
13
|
Modulation of gene expression by Pseudomonas aeruginosa during chronic infection in the adult cystic fibrosis lung.
|
Microbiology
|
2013
|
0.83
|
14
|
Proteomics of Pseudomonas aeruginosa Australian epidemic strain 1 (AES-1) cultured under conditions mimicking the cystic fibrosis lung reveals increased iron acquisition via the siderophore pyochelin.
|
J Proteome Res
|
2011
|
0.81
|
15
|
Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strain.
|
BMC Microbiol
|
2012
|
0.80
|
16
|
Multi-centre research in Australia: analysis of a recent National Health and Medical Research Council-funded project.
|
Respirology
|
2009
|
0.80
|
17
|
Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
|
Respirology
|
2010
|
0.77
|
18
|
Comparative analysis of multidrug-resistant, non-multidrug-resistant, and archaic methicillin-resistant Staphylococcus aureus isolates from Central Sydney, Australia.
|
J Clin Microbiol
|
2003
|
0.77
|
19
|
High prevalence of a class 1 integron-associated aadB gene cassette in Pseudomonas aeruginosa isolates from an Australian cystic fibrosis patient population.
|
Pathology
|
2008
|
0.75
|